We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-2.62%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.84B
AUM Growth
-$154M
Cap. Flow
+$25M
Cap. Flow %
0.52%
Top 10 Hldgs %
18.29%
Holding
1,493
New
82
Increased
580
Reduced
615
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 18.65%
2 Financials 10.44%
3 Healthcare 9.35%
4 Industrials 8.91%
5 Consumer Discretionary 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVST icon
1351
Microvast
MVST
$291M
$37.6K ﹤0.01%
19,901
+3,901
+24% +$8.35K
ONDS icon
1352
Ondas Inc
ONDS
$5.31B
$35.4K ﹤0.01%
58,140
CGEN icon
1353
Compugen
CGEN
$221M
$33.5K ﹤0.01%
36,000
-16,000
-31% -$17.6K
EQRX
1354
DELISTED
EQRx, Inc. Common Stock
EQRX
$33.3K ﹤0.01%
15,000
LUMN icon
1355
Lumen
LUMN
$6.85B
$32.2K ﹤0.01%
22,701
-414
-2% -$701
PIII icon
1356
P3 Health Partners
PIII
$42.7M
$31.5K ﹤0.01%
429
IAG icon
1357
IAMGOLD
IAG
$10.5B
$30.8K ﹤0.01%
14,348
+388
+3% +$956
GRWG icon
1358
GrowGeneration
GRWG
$85.9M
$29.3K ﹤0.01%
10,040
-4,525
-31% -$14.8K
UXIN
1359
Uxin Ltd
UXIN
$257M
$27.2K ﹤0.01%
1,667
RGTI icon
1360
Rigetti Computing
RGTI
$5.89B
$26.6K ﹤0.01%
20,000
-20,000
-50% -$38.4K
MLSS icon
1361
Milestone Scientific
MLSS
$42M
$25.3K ﹤0.01%
27,500
ATRA icon
1362
Atara Biotherapeutics
ATRA
$77.6M
$24.6K ﹤0.01%
666
-237
-26% -$10.5K
VERU icon
1363
Veru
VERU
$44.5M
$20.4K ﹤0.01%
2,837
+450
+19% +$4.9K
AKTS
1364
DELISTED
Akoustis Technologies Inc
AKTS
$19.2K ﹤0.01%
25,525
+9,000
+54% +$16.6K
SPCE icon
1365
Virgin Galactic
SPCE
$489M
$19K ﹤0.01%
527
-120
-19% -$7.16K
MREO
1366
Mereo BioPharma
MREO
$43.5M
$18.1K ﹤0.01%
14,000
CD
1367
Chaince Digital Holdings
CD
$227M
$16K ﹤0.01%
11,250
TELL
1368
DELISTED
Tellurian Inc.
TELL
$15.1K ﹤0.01%
13,000
BFLY icon
1369
Butterfly Network
BFLY
$2.58B
$13.8K ﹤0.01%
11,700
BARK icon
1370
BARK
BARK
$96.7M
$13.8K ﹤0.01%
575
WRN
1371
Western Copper and Gold
WRN
$555M
$13.7K ﹤0.01%
10,000
RVP icon
1372
Retractable Technologies
RVP
$20.1M
$11.9K ﹤0.01%
10,020
NVTA
1373
DELISTED
Invitae Corporation
NVTA
$7.5K ﹤0.01%
12,400
-16,500
-57% -$17.1K
OTLK icon
1374
Outlook Therapeutics
OTLK
$215M
$5.44K ﹤0.01%
1,230
+550
+81% +$12.2K
RAD
1375
DELISTED
Rite Aid Corporation
RAD
$4.69K ﹤0.01%
10,470
-62
-0.6% -$83

Similar funds

Oppenheimer & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Oppenheimer & Co held 1,493 positions worth $4.84B, down 3.1% from $5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q3 2023 filing shows 82 new, 580 increased, 615 reduced and 118 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M. The largest sale was FT Vest US Equity Deep Buffer ETF December, an estimated $15.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2023 buy was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M.
  • Oppenheimer & Co added most to ConocoPhillips in Q3 2023, an estimated $4.53M increase.
  • Oppenheimer & Co's biggest Q3 2023 reduction was Equitrans Midstream Corporation Common Stock, cutting an estimated $7.88M.
  • Oppenheimer & Co fully exited FT Vest US Equity Deep Buffer ETF December in Q3 2023, selling an estimated $15.1M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $4.84B portfolio in Q3 2023.
  • Oppenheimer & Co opened 82 new positions and closed 118 in Q3 2023.
  • Oppenheimer & Co's portfolio value fell 3.1% quarter-over-quarter to $4.84B.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.